CDMO (avidbio.com) Rasio Nilai Pasar marang Nilai Buku

Avid Bioservices, Inc. (CDMO) focuses on expanding its protein and antibody production capacities. The market's revaluation coefficient of balance sheet capital demonstrates the current brand value, with the latest mark standing at 18.00. A stable order book ensures balance, although investments in laboratories are temporarily reducing cash. Meanwhile, sector volatility and strict FDA regulations create certain risks for margins.

Seamless integration with raw material suppliers minimizes operational risks for Avid Bioservices, Inc. (CDMO). This resilience is reflected in the 18.00 value, which compares the business value to its net assets. The metric determines the market premium over the book value of equity, measuring resource efficiency. A high ratio signals inflated investor expectations. The dynamics of these processes are illustrated in the historical price action of the market-to-book capitalization multiple.